KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Assets (2016 - 2025)

Historic Current Assets for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $13.9 billion.

  • Teva Pharmaceutical Industries' Current Assets rose 1110.58% to $13.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.9 billion, marking a year-over-year increase of 1110.58%. This contributed to the annual value of $13.9 billion for FY2025, which is 1110.58% up from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Current Assets of $13.9 billion as of Q4 2025, which was up 1110.58% from $12.7 billion recorded in Q3 2025.
  • Teva Pharmaceutical Industries' Current Assets' 5-year high stood at $13.9 billion during Q4 2025, with a 5-year trough of $11.4 billion in Q3 2023.
  • Its 5-year average for Current Assets is $12.3 billion, with a median of $12.3 billion in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 762.99% in 2023, then surged by 1110.58% in 2025.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Current Assets stood at $12.6 billion in 2021, then fell by 4.15% to $12.1 billion in 2022, then grew by 3.6% to $12.5 billion in 2023, then grew by 0.54% to $12.6 billion in 2024, then grew by 11.11% to $13.9 billion in 2025.
  • Its last three reported values are $13.9 billion in Q4 2025, $12.7 billion for Q3 2025, and $12.6 billion during Q2 2025.